Advertisement

Loading...

Elife Holdings Limited

0223.HKHKSE
Financial Services
Financial - Capital Markets
HK$0.14
HK$0.03(25.00%)
Hong Kong Market is Open • 13:04

Elife Holdings Limited Fundamental Analysis

Elife Holdings Limited (0223.HK) shows weak financial fundamentals with a PE ratio of -8.59, profit margin of -19.78%, and ROE of -44.09%. The company generates $0.1B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position11.64%
PEG Ratio-0.13
Current Ratio1.57

Areas of Concern

ROE-44.09%
Operating Margin-9.93%
We analyze 0223.HK's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -44.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-44.5/100

We analyze 0223.HK's fundamental strength across five key dimensions:

Efficiency Score

Weak

0223.HK struggles to generate sufficient returns from assets.

ROA > 10%
-16.27%

Valuation Score

Excellent

0223.HK trades at attractive valuation levels.

PE < 25
-8.59
PEG Ratio < 2
-0.13

Growth Score

Weak

0223.HK faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

0223.HK maintains a strong and stable balance sheet.

Debt/Equity < 1
0.45
Current Ratio > 1
1.57

Profitability Score

Weak

0223.HK struggles to sustain strong margins.

ROE > 15%
-4409.32%
Net Margin ≥ 15%
-19.78%
Positive Free Cash Flow
No

Key Financial Metrics

Is 0223.HK Expensive or Cheap?

P/E Ratio

0223.HK trades at -8.59 times earnings. This suggests potential undervaluation.

-8.59

PEG Ratio

When adjusting for growth, 0223.HK's PEG of -0.13 indicates potential undervaluation.

-0.13

Price to Book

The market values Elife Holdings Limited at 3.60 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.60

EV/EBITDA

Enterprise value stands at -8.95 times EBITDA. This is generally considered low.

-8.95

How Well Does 0223.HK Make Money?

Net Profit Margin

For every $100 in sales, Elife Holdings Limited keeps $-19.78 as profit after all expenses.

-19.78%

Operating Margin

Core operations generate -9.93 in profit for every $100 in revenue, before interest and taxes.

-9.93%

ROE

Management delivers $-44.09 in profit for every $100 of shareholder equity.

-44.09%

ROA

Elife Holdings Limited generates $-16.27 in profit for every $100 in assets, demonstrating efficient asset deployment.

-16.27%

Following the Money - Real Cash Generation

Operating Cash Flow

Elife Holdings Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

Elife Holdings Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

0223.HK converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-8.59

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.13

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.60

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.70

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.45

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.57

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.44

vs 25 benchmark

ROA

Return on assets percentage

-0.16

vs 25 benchmark

ROCE

Return on capital employed

-0.22

vs 25 benchmark

How 0223.HK Stacks Against Its Sector Peers

Metric0223.HK ValueSector AveragePerformance
P/E Ratio-8.5918.56 Better (Cheaper)
ROE-44.09%828.00% Weak
Net Margin-19.78%-175.00% (disorted) Weak
Debt/Equity0.451.00 Strong (Low Leverage)
Current Ratio1.57663.54 Neutral
ROA-16.27%-21308.00% (disorted) Weak

0223.HK outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Elife Holdings Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Value, Dividend, Cyclical

EPS CAGR

N/A

Industry Style: Value, Dividend, Cyclical

FCF CAGR

N/A

Industry Style: Value, Dividend, Cyclical

Fundamental Analysis FAQ